Effects of radical oxygen species and no: Formation of intracellular hypoxia and activation of matrix metalloproteinases in tumor tissues

Experimental Oncology

Volumn 28, Issue 1, 2006, Pages 49-53

  Burlaka, A P ^a   Sidorik, E P ^a   Ganusevich, I I ^a   Osinsky, S P ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

Carcinogenesis; Cell hypoxia; Electron paramagnetic resonance; Matrix metalloproteinases; Mitochondria; Nitric oxide; Radical oxygen species; Spin trap

Indexed keywords

GELATINASE A; GELATINASE B; LIQUID NITROGEN; NITRIC OXIDE; POLYACRYLAMIDE GEL; RADICAL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CARCINOGENESIS; CELL HYPOXIA; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CANCER; MALE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NEUTROPHIL; NONHUMAN; OXIDATION REDUCTION REACTION; RAT; ROOM TEMPERATURE; STOMACH CANCER; TUMOR CELL;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL HYPOXIA; DISEASE MODELS, ANIMAL; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENZYME ACTIVATION; FEMALE; HUMANS; LIVER NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASES; NITRIC OXIDE; RATS; REACTIVE OXYGEN SPECIES; STOMACH NEOPLASMS;

EID: 33646037963     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kushnareva Y, Murphy AN, Andreyev A. Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. Biochem J 2002; 368: 545-53.
2. Turrens JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep 1997; 17: 3-8.
3. Liang-Jun Yan, Rodney L, Levine E, Sohal RS. Oxidative damage during aging targets mitochondrial aconitase. Proc Natl Acad Sci U S A 1997; 94: 11168-72.
4. Lenaz G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 2001; 52: 159-64.
5. Trumpower BL. The protonmotive Q cycle. J Biol Chem 1990; 265: 11409-12.
6. Burlaka AP, Danko MI, Sidorik EP. Kinetic patterns of the rate of generation and content of oxygen radicals in membranes of endoplasmic reticulum upon chemical carcinogenesis of liver and mammary gland. Dop Acad Sci Ukr 1994; 10: 141-5 (In Ukrainian).
7. Elfering SL, Haynes VL, Traaseth NJ, Ettl A, Giulivi C. Aspects, mechanism, and biological relevance of mitochondrial protein nitration sustained by mitochondrial nitric oxide synthase. Am J Physiol Heart Circ Physiol 2004; 285: 22-9.
8. Davidson B, Reich R, Risberg B, Nesland JM. The biological role and regulation of matrix metalloproteinases (MMP) in cancer. Arch Pathol 2002; 3: 47-53.
9. Kumar DA, Raju KV, Settu K, Kumanan K, Puvanakrishnan R. Effect of a derivatized tetrapeptide from lactoferrin on nitric oxide mediated matrix metalloproteinase-2 production by synovial fibroblasts in collagen-induced arthritis in rats. Peptides 2005; 5: 42-9.
10. Egger B, Aubert JD. Pulmonary emphyzema: mechanisms and therapeutic perspectives. Rev Med Suisse 2005; 16: 2665-72.
11. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000; 36: 1621-30.
12. Engers R, Gabbert HE. Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J Cancer Res Clin Oncol 2000; 126: 682-92.
13. Vihinen P, Kahari V-M. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 2002; 99: 157-66.
14. Chan LW, Moses MA, Goley E, Sproull M, Muanza T, Coleman CN, Figg WD, Albert PS, Menard C, Camphausen K. Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy. J Clin Oncol 2004; 22: 499-506.
15. Kato K, Hara A, Kuno T, Kitaori N, Huilan Z, Mori H, Toida M, Shibata T. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity. J Cancer Res Clin Oncol 2005; 131: 340-6.
16. Panasenko OM, Chekanov AV, Arnold Yu, Sergienko VI, Osipov AN, Vladimirov YuA. Generation of free radicals upon degradation of hydroperoxide in the presence of myeoloperoxydase or activated neutrophils. Biochemistry 2005; 70: 1209-17 (In Russian).
17. Nedelijkovic ZS, Gekce M, Loscalzo J. Mechanisms of oxidative stress and vascular dysfunction. Postgraduate Med J 2005; 79: 195-200.
18. De Clerck YA, Perez N, Shimada H, Boone TC, Langley RE, Taylor SM. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992; 52: 701-8.
19. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
20. Sharpe MA, Cooper CE. Interaction of peroxynitrite with mitochondrial cytochrome oxidase. Catalytic production of nitric oxide and irreversible inhibition of enzyme activity. J Biol Chem 1998; 273: 30961-72.
21. Brown GC. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta 2001; 1504: 46-57.
22. Torres J, Sharpe MA, Rosquist A, Cooper CE, Wilson M. Cytochrome c oxidase rapidly metabolises nitric oxide to nitrite. FEBS Lett 2000; 475: 243-66.
23. Radi R, Denicola A, Alvlrez B, Ferrer-Sueta G, Rubbo H. The biological chemistry of peroxynitrite. USA Acad Press 2000; 57-82.
24. Osinsky S, Ganusevich I, Bubnovskaya L, Valkovskaya N, Kovelskaya A, Sergienko T, Zimina S. Hypoxia level and matrix metalloproteinases-2 and -9 activity in Lewis lung carcinoma: correlation with metastasis. Exp Oncol 2005; 27: 202-5.